Filing Details
- Accession Number:
- 0001209191-19-014283
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-27 20:11:09
- Reporting Period:
- 2019-02-25
- Accepted Time:
- 2019-02-27 20:11:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1277462 | Karen Gibson | 12544 High Bluff Drive, Suite 200 San Diejo CA 92130 | Svp, Is & Bus. Transformation | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-25 | 2,449 | $15.40 | 7,545 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-25 | 2,449 | $68.44 | 5,096 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-02-27 | 13,551 | $15.40 | 18,647 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-27 | 13,551 | $66.23 | 5,191 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Options | Disposition | 2019-02-25 | 2,449 | $0.00 | 2,449 | $15.40 |
| Common Stock | Non-Qualified Stock Options | Disposition | 2019-02-27 | 13,551 | $0.00 | 13,551 | $15.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 19,057 | 2026-02-10 | No | 4 | M | Direct | |
| 5,506 | 2026-02-10 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for these transactions was $68.436 per share, with a range of $68.22 to $68.78. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $66.2282 per share, with a range of $66.00 to $66.50. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The amount of securities beneficially owned prior to this transaction included an additional 95 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
- 10,754 shares vested on 02/10/2018; 5,376 shares vested on 02/10/2019; 5,375 shares will vest on 02/10/2020.
Billionaire Hedge Funds
